Revision 10 for 'Cardiac amyloidosis'

All Revisions - View changeset

Cardiac amyloidosis

Cardiac amyloidosis is a significant source of morbidity among patients with systemic amyloidosis, and is the most common cause of restrictive cardiomyopathy outside the tropics.

Amyloidosis represents the extra-cellular deposition of insoluble fibrillar proteinaceous material in various organs and tissues in a variety of clinical settings. For a general discussion of the condition please refer to amyloidosis

Cardiac involvement is seen with most forms of amyloidosis, although it is most common and most often clinically significant with primary amyloidosis (i.e associated with multiple myeloma or other monoclonal gammopathies).

Radiographic features


MRI is the modality of choice for evaluating cardiac amyloidosis. Features include:

  • diffuse heterogeneous pattern of increased signal on delayed contrast enhanced inversion recovery T1-weighted images (this is a characteristic feature)
  • left ventricular wall thickening
  • reduced systolic function with decreased ejection fraction
  • restriction of diastolic filling
  • disproportionate atrial enlargement

Differential diagnosis

Cardiac amyloidosis needs to be distinguished from other forms of restrictive cardiomyopathy, including:

See also

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.